Stephen  Furlong net worth and biography

Stephen Furlong Biography and Net Worth

CFO of Neuronetics
Stephen Furlong serves as Vice President, Chief Financial Officer, Office of the President of the Company. He has served as our Vice President and Chief Financial Officer since July 2019 and as a member of the Office of the President of the Company since March 5, 2020 following Mr. Thatcher’s resignation as our Chief Executive Officer and President. Prior to joining the company, Mr. Furlong worked at Metabolon, a private life science company in metabolomics, a phenotyping technology for advancing biomarker discovery, diagnostic testing and precision medicine, from November 2017 to July 2019, where he most recently served as Senior Vice President of Finance and Corporate Secretary. Prior to joining Metabolon, Mr. Furlong was Vice President Finance at Verscend Technologies from February 2017 to June 2017. From April 2015 to September 2016, he served as Chief Financial Officer of Rapid Micro Biosystems, which manufactures and distributes products for detection of microbial contamination. Before joining Rapid Micro Biosystems, Mr. Furlong spent 14 years at Hologic, a publicly-traded medical technology company, where he held a number of roles of increasing responsibilities, most recently Senior Vice President, Finance and Sales Administration. Prior to his experience at Hologic, Mr. Furlong held positions at Safety 1st, Stratus Computer Inc., and Raytheon Company. Mr. Furlong received his B.A. in Political Science from The Pennsylvania State University and his Master of Finance degree from Bentley University.

What is Stephen Furlong's net worth?

The estimated net worth of Stephen Furlong is at least $2.32 million as of February 27th, 2024. Mr. Furlong owns 487,761 shares of Neuronetics stock worth more than $2,321,742 as of March 28th. This net worth evaluation does not reflect any other assets that Mr. Furlong may own. Additionally, Mr. Furlong receives an annual salary of $787,870.00 as CFO at Neuronetics. Learn More about Stephen Furlong's net worth.

How old is Stephen Furlong?

Mr. Furlong is currently 60 years old. There are 2 older executives and no younger executives at Neuronetics. The oldest executive at Neuronetics is Mr. Keith J. Sullivan, President, CEO & Director, who is 66 years old. Learn More on Stephen Furlong's age.

What is Stephen Furlong's salary?

As the CFO of Neuronetics, Inc., Mr. Furlong earns $787,870.00 per year. The highest earning executive at Neuronetics is Mr. Keith J. Sullivan, President, CEO & Director, who commands a salary of $1,530,000.00 per year. Learn More on Stephen Furlong's salary.

How do I contact Stephen Furlong?

The corporate mailing address for Mr. Furlong and other Neuronetics executives is 3222 PHOENIXVILLE PIKE, MALVERN PA, 19355. Neuronetics can also be reached via phone at (610) 640-4202 and via email at [email protected]. Learn More on Stephen Furlong's contact information.

Has Stephen Furlong been buying or selling shares of Neuronetics?

Over the course of the past ninety days, Stephen Furlong has sold $142,173.93 in shares of Neuronetics stock. Most recently, Stephen Furlong sold 21,272 shares of the business's stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $3.33, for a transaction totalling $70,835.76. Following the completion of the sale, the chief financial officer now directly owns 487,761 shares of the company's stock, valued at $1,624,244.13. Learn More on Stephen Furlong's trading history.

Who are Neuronetics' active insiders?

Neuronetics' insider roster includes Robert Cascella (Director), Sheryl Conley (Director), Stephen Furlong (CFO), Gregory Harper (VP), William Macan (VP), Bruce Shook (Director), and Keith Sullivan (CEO). Learn More on Neuronetics' active insiders.

Are insiders buying or selling shares of Neuronetics?

In the last twelve months, insiders at the sold shares 17 times. They sold a total of 202,262 shares worth more than $610,676.94. The most recent insider tranaction occured on February, 28th when EVP William Andrew Macan sold 22,377 shares worth more than $70,711.32. Insiders at Neuronetics own 7.3% of the company. Learn More about insider trades at Neuronetics.

Information on this page was last updated on 2/28/2024.

Stephen Furlong Insider Trading History at Neuronetics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/27/2024Sell21,272$3.33$70,835.76487,761View SEC Filing Icon  
2/9/2024Sell14,710$3.51$51,632.10509,033View SEC Filing Icon  
2/6/2024Sell5,813$3.39$19,706.07523,743View SEC Filing Icon  
10/6/2023Sell1,499$1.16$1,738.84429,556View SEC Filing Icon  
3/7/2023Sell11,079$4.59$50,852.61431,055View SEC Filing Icon  
2/14/2023Sell12,403$5.58$69,208.74455,282View SEC Filing Icon  
2/7/2023Sell5,584$5.99$33,448.16367,685View SEC Filing Icon  
1/17/2023Sell16,050$6.13$98,386.50373,269View SEC Filing Icon  
10/11/2022Sell1,630$2.97$4,841.10389,319View SEC Filing Icon  
7/25/2022Sell13,321$3.54$47,156.34390,949View SEC Filing Icon  
3/9/2022Sell10,029$3.00$30,087.00View SEC Filing Icon  
2/8/2022Sell5,184$3.12$16,174.08View SEC Filing Icon  
1/24/2022Sell268$3.40$911.20View SEC Filing Icon  
1/21/2022Sell17,189$3.62$62,224.18View SEC Filing Icon  
7/28/2021Sell6,563$13.08$85,844.04View SEC Filing Icon  
6/4/2021Sell2,473$15.00$37,095.00257,012View SEC Filing Icon  
5/20/2021Sell24,080$15.04$362,163.20277,012View SEC Filing Icon  
3/9/2021Sell6,521$14.64$95,467.44289,971View SEC Filing Icon  
1/21/2021Sell7,585$18.21$138,122.85261,316View SEC Filing Icon  
3/10/2020Buy25,000$2.00$50,000.00274,184View SEC Filing Icon  
11/15/2019Buy22,959$4.40$101,019.60
See Full Table

Stephen Furlong Buying and Selling Activity at Neuronetics

This chart shows Stephen Furlong's buying and selling at Neuronetics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Neuronetics Company Overview

Neuronetics logo
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Read More

Today's Range

Now: $4.76
Low: $4.64
High: $4.91

50 Day Range

MA: $3.64
Low: $2.79
High: $4.80

2 Week Range

Now: $4.76
Low: $1.03
High: $4.99

Volume

64,274 shs

Average Volume

242,493 shs

Market Capitalization

$141.66 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.38